Trial Profile

A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 23 Nov 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Linsitinib (Primary) ; Sorafenib
Indications Liver cancer
Focus Biomarker; Therapeutic Use

Most Recent Events

11 Oct 2012 Actual end date Dec 2011 added as reported by ClinicalTrials.gov.
14 Aug 2012 Actual initiation date changed from Apr 2011 to Mar 2011 as reported by ClinicalTrials.gov.
14 Aug 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com